Dendreon shares Left for Dead?
There are the crazy price targets such as $18 by Maxim Group set in September and more reasonable $7 from Baird back in August. Going with BofA would represent a 44% increase to get back to $6 from today's price. Take a look at the crack price tp of $18, a 300%+ increase in the next 12 months...really?
|Ticker||Current Price||Target Price||% Increase|
Dendreon reports Q3 earnings at the end of the month on October 30th. Expect the stock to tread water until we hear something at that time. What could work for playing the conference call is a covered call on DNDN to protect your neck.
MASTERY Bottom line:
Provenge has a bunch of competition and when it costs $100K per patient, its not going to everyone who could really benefit from it.
Medivation (MDVN) and Astellas Pharma (ALPMY.PK) are getting ready to take on Provenge with their prostate cancer fighting drug Xtandi. There is room in the prostate cancer arena, these drugs are used at different stages of treating prostate cancer. Johnson & Johnson's (JNJ) Zytiga is also competing in this space as is Jevtana from Sanofi. The prostate cancer treatment field is getting crowded, its why DNDN has tanked to $4.
However Dendreon isn't dead yet. The stock can go lower but at $4 its worth a few bucks to go long.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- The Return Of Crisis | ZeroHedge
- It's Not March 2009... And That's Bad | Financial Sense
- Hillary Has A Big Problem With "Everyday Americans" | ZeroHedge
- Oil Prices Down Again on Energy Debt and Inventories Data | Financial Sense
- Global Stocks Enter Bear Market | ZeroHedge
- Sweden Slides Further Into NIRP, Cuts Rates To -0.50% | ZeroHedge
- USDJPY Plunges To 113 Handle - Gives Up QQE2 Gains | ZeroHedge
The most relevant financial news and articles from the Internets
- Hope Solo says she might skip the Olympics because of Zika | Business Insider
- 23 signs you're burnt out at work | Business Insider
- The first exit polls from New Hampshire are out, and they have some interesting nuggets | Business Insider
- Crazy play during Super Bowl shows how much trouble players had... | Business Insider
- TRUMP WINS NEW HAMPSHIRE | Business Insider
- This guy does incredible tricks with pizza dough | Business Insider
- This study provides clear evidence of how Zika virus may be causing birth defects | Business Insider